Back to search
FDAFDA · Food and drugs·Recall number D-0336-2024

Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015. Made in Ireland. NDC: 0338-0108-20

Published February 28, 2024 · Recall initiated: January 23, 2024

Summary

FDA records drug Class II recall D-0336-2024, published February 28, 2024 and initiated January 23, 2024. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 13,000 bags; Lot: Lot 23I21G64; Exp. 07/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.

What to do

Voluntary: Firm initiated · Letter

Get an email if NOREPINEPHRINE BITARTRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NOREPINEPHRINE BITARTRATE
Manufacturer
Baxter Healthcare Corporation
Distributor
Nationwide in the USA
Lot
Lot 23I21G64; Exp. 07/31/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015. Made in Ireland. NDC: 0338-0108-20 recalled?

Yes. FDA published recall D-0336-2024 on February 28, 2024. Reported hazard: Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NOREPINEPHRINE BITARTRATE.